Overview ACCOLADE™ and ESSENTIO™ pacemakers provide respiration-based RightRate™ pacing, automatic daily remote monitoring and in-device diagnostics for implantable single- and dual-chamber pacing therapy in clinical settings.
Key Features - RightRate™ respiration-based pacing: minute ventilation sensor clinically proven to restore chronotropic competence.
- Boston Scientific battery technology: 1.6 ampere-hour (Ah) EL batteries labeled life between 9.5 and 16.7 years.
- Automatic Daily Monitoring: supports the LATITUDE™ NXT Patient Management System to streamline remote follow-up and clinic workflow.
- Post-Operative System Test (POST): fully automatic evaluation of lead impedances, intrinsic amplitudes and capture thresholds prior to discharge.
- Atrial Arrhythmia Report: delivers a comprehensive view of AT/AF status to support assessment of atrial fibrillation therapy.
Available Models - ACCOLADE Model L301
- ACCOLADE EL - Model L321
- ESSENTIO Model L101
- ESSENTIO EL Model L121
Key Resources - Directions for Use
- RightRate™ Clinical Brochure
- Indications, Safety and Warnings (prescriptive information)
- Mechanical specification sheets: ACCOLADE Models L300 and L301 Spec Sheet; ACCOLADE Model L321 Spec Sheet; ESSENTIO Models L100 and L101 Spec Sheet; ESSENTIO Model L121 Spec Sheet.
Technical specifications - Sensor: RightRate™ minute ventilation sensor — clinically proven to restore chronotropic competence.
- Battery: 1.6 Ah EL batteries (labeled life between 9.5 and 16.7 years).
- Remote monitoring: Automatic daily monitoring compatible with the LATITUDE™ NXT Patient Management System.
- Diagnostics: Post-Operative System Test (POST) for automatic lead and capture evaluation prior to discharge.
- Arrhythmia reporting: Atrial Arrhythmia Report for AT/AF status and treatment assessment.
- Product type: Implantable single- and dual-chamber pacemakers available in ACCOLADE™ and ESSENTIO™ model variants (see Available Models).